The DOI matches its Crossref record; 280 of the 281 references it cites were found in a registry or an index.
The FGF family: biology, pathophysiology and therapy
Open accessAbstract
The family of fibroblast growth factors (FGFs) regulates a plethora of developmental processes, including brain patterning, branching morphogenesis and limb development. Several mitogenic, cytoprotective and angiogenic therapeutic applications of FGFs are already being explored, and the recent discovery of the crucial roles of the endocrine-acting FGF19 subfamily in bile acid, glucose and phosphate homeostasis has sparked renewed interest in the pharmacological potential of this family. This Review discusses traditional applications of recombinant FGFs and small-molecule FGF receptor kinase inhibitors in the treatment of cancer and cardiovascular disease and their emerging potential in the treatment of metabolic syndrome and hypophosphataemic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a non-canonical fibroblast growth factor, fibroblast growth factor 21 (FGF21) functions as an endocrine hormone that signals to distinct targets throughout the body.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Thalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., & Ornitz, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90512-w · Cited by 2,440
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., & Blum, R. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.7 · Cited by 2,089
Suppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,865
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh‐Hain, J. A., Tamez, H. E., Shah, A., Smith, K. T., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,729
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citation
Flagged first, then by citations
1 of the 281 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Aono Y, et al. The neutralization of FGF-23 ameliorates hypophosphatemia and rickets in Hyp mice. J. Bone Miner. Res. 18, S16 (2003).
Cited by
Sorted by citations
Items 801–900 of 1,001
Environmental regulation of valvulogenesis: implications for tissue engineering
Vis, P. W. R., Kluin, J., Sluijter, J. P. G., van Herwerden, L. A., & Bouten, C. V. C. (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.05.032 · Cited by 25
Cheema, U., Alekseeva, T., Neel, E. A. A., & Brown, R. A. (2010) · European Cells and Materials · doi:10.22203/ecm.v020a22 · Cited by 25
Zhang, X., Lv, H., Zhou, Q. S., Elkholi, R., Chipuk, J. E., Reddy, M. V. R., Reddy, E. P., & Gallo, J. M. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0847 · Cited by 25
Fibroblast Growth Factor Family in the Progression of Prostate Cancer
Teishima, J., Hayashi, T., Nagamatsu, H., Shoji, K., Shikuma, H., Yamanaka, R., Sekino, Y., Goto, K., Inoue, S., & Matsubara, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020183 · Cited by 29
Fibroblast Growth Factor 1 Promotes Rat Stem Leydig Cell Development
Chen, L., Li, X., Wang, Y., Song, T., Li, H., Xie, L., Li, L., Chen, X., Ma, L., Chen, Y., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00118 · Cited by 25
Genome-Wide Association Study of Opioid Cessation
Cox, J. W., Sherva, R., Lunetta, K. L., Johnson, E. C., Martin, N. G., Degenhardt, L. J., Arpana Agrawal, A., Nelson, E. C., Kranzler, H. R., Gelernter, J. E., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010180 · Cited by 28
Repetto, M., Crimini, E., Giugliano, F., Morganti, S., Belli, C., & Curigliano, G. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1947246 · Cited by 25
Naumnik, W., Ossolińska, M., Płońska, I., Chyczewska, E., & Nikliński, J. (2014) · Advances in experimental medicine and biology · doi:10.1007/5584_2014_78 · Cited by 25
The roles of FGFR3 and c-MYC in urothelial bladder cancer
Bogale, D. E. (2024) · Discover Oncology · doi:10.1007/s12672-024-01173-z · Cited by 27
Lin, Q., Zhang, S., Zhang, J., Jin, Y., Chen, T., Lin, R., Lv, J., Xu, W., Wu, T., Tian, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58644-2 · Cited by 26
Regenerative Chemical Biology: Current Challenges and Future Potential
Ao, A. S., Hao, J., & Hong, C. C. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.03.011 · Cited by 24
Interaction of the receptor FGFRL1 with the negative regulator Spred1
Zhuang, L., Villiger, P. M., & Trüeb, B. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.006 · Cited by 24
Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements
Paradiso, B., Zucchini, S., & Simonato, M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00152 · Cited by 24
The fibroblast growth factor 8 family in the female reproductive tract
Estienne, A., & Price, C. A. (2017) · Reproduction · doi:10.1530/rep-17-0542 · Cited by 25
Stöhr, O., Tao, R., Miao, J., Copps, K. D., & White, M. F. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108893 · Cited by 24
Peptides Derived from Growth Factors to Treat Alzheimer’s Disease
Gascon, S., Jann, J., Langlois-Blais, C., Plourde, M., Lavoie, C. L., & Faucheux, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116071 · Cited by 24
Endocrine Fibroblast Growth Factors in Relation to Stress Signaling
Shimizu, M., & Sato, R. (2022) · Cells · doi:10.3390/cells11030505 · Cited by 25
Moes-Sosnowska, J., & Chorostowska-Wynimko, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.780650 · Cited by 21
Guo, L., Liu, J., Nie, X., Wang, T., Ma, Z., Yin, D., & Tang, W. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128982 · Cited by 24
Prospective use of amniotic mesenchymal stem cell metabolite products for tissue regeneration
Miatmoko, A., Hariawan, B. S., Cahyani, D. M., Dewangga, S. S., Handoko, K. K., Purwati, P., Sahu, R. K., & Hariyadi, D. M. (2023) · Journal of Biological Engineering · doi:10.1186/s13036-023-00331-1 · Cited by 24
Chen, C., Wang, J., Liu, C., Hu, J., & Liu, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115306 · Cited by 25
Singla, D. K., & Wang, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5810908 · Cited by 24
Gene Therapy to Stimulate Angiogenesis to Treat Diffuse Coronary Artery Disease
Kaminsky, S. M., Rosengart, T. K., Rosenberg, J. B., Chiuchiolo, M. J., de Graaf, B. G. V., Sondhi, D., & Crystal, R. G. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.2516 · Cited by 24
Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer
Inokuchi, M., Fujimori, Y., Otsuki, S., Sato, Y., Nakagawa, M., & Kojima, K. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/796380 · Cited by 24
Zheng, L., Hui, Q., Tang, L., Zheng, L., Jin, Z., Yu, B., Wang, Z., Lin, P., Wei-dan, Y., Li, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135291 · Cited by 24
Park, Y. S., Na, Y.-S., Ryu, M., Lee, C., Park, H. J., Lee, J., Park, S. R., Ryoo, B., & Kang, Y. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpnflsmwwpp8dr · Cited by 24
Claycombe, K., Vomhof‐DeKrey, E. E., Garcia, R. A. G., Johnson, W. T., Uthus, E. O., & Roemmich, J. N. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.01.008 · Cited by 24
MicroRNA-34a and Impaired FGF19/21 Signaling in Obesity
Fu, T., & Kemper, J. K. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.02.002 · Cited by 24
Heparin-binding peptide as a novel affinity tag for purification of recombinant proteins
Morris, J., Jayanthi, S., Langston, R. G., Daily, A. E., Kight, A. D., McNabb, D. S., Henry, R. L., & Kumar, T. K. S. (2016) · Protein Expression and Purification · doi:10.1016/j.pep.2016.05.013 · Cited by 24
Bartz, R., Fukuchi, K., Ohtsuka, T., Lange, T., Grüner, K., Watanabe, I., Hayashi, S., Oda, Y., Kawaida, R., Komori, H., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0048 · Cited by 23
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
Cymbaluk‐Płoska, A., Gargulińska, P., Chudecka-Glaz, A. M., Kwiatkowski, S., Pius‐Sadowska, E., & Machaliński, B. (2020) · Diagnostics · doi:10.3390/diagnostics10060414 · Cited by 23
FGF signaling in cranial suture development and related diseases
Zhao, X., Erhardt, S., Sung, K., & Wang, J. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1112890 · Cited by 25
Therapeutic utilities of fibroblast growth factor 19
Wu, X., & Li, Y. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.624514 · Cited by 23
Lelliott, C. J., Ahnmark, A., Admyre, T., Ahlstedt, I., Irving, L. M., Keyes, F., Patterson, L. M., Mumphrey, M. B., Bjursell, M., Gorman, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112109 · Cited by 23
Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease
Rysz, J., Gluba-Brzózka, A., Mikhailidis, D. P., & Banach, M. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1006357 · Cited by 23
Zhou, W., Du, X., Song, F., Zheng, H., Chen, K., Zhang, W., & Yang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8067 · Cited by 23
Zhen, Y., Haugsten, E. M., Singh, S. K., & Wesche, J. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00120 · Cited by 23
VEGF and FGF signaling during head regeneration in hydra
Turwankar, A., & Ghaskadbi, S. (2019) · Gene · doi:10.1016/j.gene.2019.144047 · Cited by 23
Autocrine FGF1 signaling promotes glucose uptake in adipocytes
Nies, V. J. M., Struik, D., Liu, S., Liu, W., Kruit, J. K., Downes, M., van Zutphen, T., Verkade, H. J., Evans, R. M., & Jonker, J. W. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122382119 · Cited by 23
Regulation of stem cell fate by HSPGs: implication in hair follicle cycling
Colin-Pierre, C., Baraka, O. E., Danoux, L., Bardey, V., André, V., Ramont, L., & Brézillon, S. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-022-00267-y · Cited by 25
Molecular regulation of satellite cells via intercellular signaling
Yeh, C.-J., Sattler, K. M., & Lepper, C. (2023) · Gene · doi:10.1016/j.gene.2023.147172 · Cited by 26
Herbert, C., Lassalle, G. Y., Alcouffe, C., & Bono, F. (2014) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.14.45 · Cited by 23
Zhang, W., Zhao, X., Xiao, Y., Chen, J., Han, P., Zhang, J., Fu, H., & Kang, Y. J. (2016) · Metallomics · doi:10.1039/c5mt00332f · Cited by 24
Zhang, M., Yu, W., Shen, X.-T., Xiang, Q., Xu, J., Yang, J., Chen, P.-P., Fan, Z.-L., Xiao, J., Zhao, Y., et al. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6639-4 · Cited by 23
Zerumbone, Sesquiterpene Photochemical from Ginger, Inhibits Angiogenesis
Park, J.-H., Park, G.-M., & Kim, J. (2015) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2015.19.4.335 · Cited by 23
Zulueta, M. M. L., Chyan, C., & Hung, S. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.03.003 · Cited by 24
Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC
Gammelgaard, K. R., Vad‐Nielsen, J., Clement, M. S., Weiss, S., Daugaard, T. F., Dagnæs‐Hansen, F., Meldgaard, P., Sørensen, B. S., & Nielsen, A. L. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.11.017 · Cited by 23
Nakamura, R., Katsuno, T., Kitamura, M., Yamashita, M., Tsuji, T., Suzuki, R., Kishimoto, Y., Suehiro, A., Tateya, I., Nakamura, T., et al. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2835 · Cited by 23
Ocker, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i3.279 · Cited by 23
Yamamoto, S., Koyama, D., Igarashi, R., Maki, T., Mizuno, H., Furukawa, Y., & Kuro‐o, M. (2020) · Internal Medicine · doi:10.2169/internalmedicine.3597-19 · Cited by 23
Zhang, L., Huang, T., Bi, J., Zheng, Y., Lü, C., Hui, Q., Wang, X., & Lin, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00058 · Cited by 23
Khalil, A. S., Xie, A. W., Johnson, H. J., & Murphy, W. L. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120007 · Cited by 23
Is Cerebrospinal Fluid Fibroblast Growth Factor 19 (FGF19) a mood regulator?
Liu, Y., Yu, D., Wang, X., Tan, X., Luo, X., Fan, H., Kang, Y., Xiao, J., Li, X., & Wang, F. (2017) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000187 · Cited by 22
Roles of FGFR in oral carcinogenesis
Xie, X., Wang, Z., Chen, F., Yao Zong, Y. U. A. N., Wang, J., Liu, R. R., & Chen, Q. (2016) · Cell Proliferation · doi:10.1111/cpr.12260 · Cited by 23
miR‑210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1
Liu, X., Zhang, C., Wang, C., Sun, J., Wang, D., Zhao, Y., & Xu, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.8939 · Cited by 22
FGF23, a novel muscle biomarker detected in the early stages of ALS
Si, Y., Kazamel, M., Benatar, M. G., Wuu, J., Kwon, Y., Kwan, T., Jiang, N., Kentrup, D., Faul, C., Alesce, L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91496-6 · Cited by 22
Fgf15 Neurons of the Dorsomedial Hypothalamus Control Glucagon Secretion and Hepatic Gluconeogenesis
Picard, A., Metref, S., Tarussio, D., Dolci, W., Berney, X. P., Croizier, S., Labouèbe, G., & Thorens, B. (2021) · Diabetes · doi:10.2337/db20-1121 · Cited by 22
Benington, L. R., Rajan, G. P., Locher, C., & Lim, L. Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111762 · Cited by 22
Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma
Jain, D., Murti, Y., Khan, W. U., Hossain, R., Hossain, M. N., Agrawal, K. K., Ashraf, R. A., Islam, M. T., Janmeda, P., Taheri, Y., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9068850 · Cited by 24
Fibroblast growth factor 21: A “rheostat” for metabolic regulation?
She, Q.-Y., Bao, J., Wang, H.-Z., Liang, H., Huang, W., Wu, J., Zhong, Y.-W., Ling, H., Li, A., & Qin, S.-L. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155166 · Cited by 22
Cooper, W. J., Wirgau, R. M., Sweet, E. M., & Albertson, R. C. (2013) · Evolution & Development · doi:10.1111/ede.12052 · Cited by 22
Heart-specific expression of FGF-16 and a potential role in postnatal cardioprotection
Wang, J., Sontag, D., & Cattini, P. A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.007 · Cited by 22
Anti-angiogenic therapy in pediatric brain tumors: An effective strategy?
Sie, M., den Dunnen, W. F. A., Hoving, E. W., & de Bont, E. S. J. M. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.09.005 · Cited by 23
Kamath, A. V., Lu, D., Gupta, P., Jin, D., Xin, Y., Brady, A., Stéphan, J.-P., Li, H., Tien, J., Qing, J., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1807-5 · Cited by 22
Computer-Aided Discovery of New Fgfr-1 Inhibitors Followed by In Vitro Validation
Alabed, S. J., Khanfar, M. A., & Taha, M. O. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0056 · Cited by 22
Lin, H., Lu, P., Zhou, M., Wu, F., Weng, L., Meng, K., Yang, D., Li, S., Jiang, C., & Tian, H. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09973-y · Cited by 21
The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism
Cariello, M., Piglionica, M., Gadaleta, R. M., & Moschetta, A. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_235 · Cited by 22
Myocardial protection by heparin-based coacervate of FGF10
Wang, Z., Huang, Y., He, Y., Khor, S., Zhong, X., Xiao, J., Ye, Q., & Li, X. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.002 · Cited by 22
Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: An Overview
Yang, W., & Sun, Y. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s297643 · Cited by 22
Cardiac Differentiation of Mesenchymal Stem Cells: Impact of Biological and Chemical Inducers
Ramesh, S., Govarthanan, K., Ostrovidov, S., Zhang, H., Hu, Q., Camci‐Unal, G., Verma, R. S., & Ramalingam, M. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10165-3 · Cited by 23
Carpenter, G. H., & Cotroneo, E. (2010) · Frontiers of oral physiology/Frontiers of oral biology · doi:10.1159/000313710 · Cited by 22
Harrison, N., del Corral, R. D., & Vasiev, B. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022700 · Cited by 22
Zhang, H., Wang, T., Zhang, K., Liu, Y., Huang, F., Zhu, X., Liu, Y., Wang, M.-H., Tang, W., Wang, J., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000226 · Cited by 22
Chang, C.-H., Huang, Y., Shyu, M., Chen, S., Lin, C., Ju, T.-K., Lu, J., & Lee, H. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.186 · Cited by 22
Englinger, B., Lötsch, D., Pirker, C., Mohr, T. T., van Schoonhoven, S., Boidol, B., Lardeau, C.-H., Spitzwieser, M., Szabó, P. T., Heffeter, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10324 · Cited by 22
Yokota, S., Chosa, N., Kyakumoto, S., Kimura, H., Ibi, M., Kamo, M., Satoh, K., & Ishisaki, A. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2896 · Cited by 22
Lu, R., Zheng, K., Zhou, Y., Wang, W., Zhang, Y., Chen, Y., Mo, M., Li, X., Dong, Y., Xie, J., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110811 · Cited by 21
Chen, P., & Simons, M. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000542 · Cited by 21
Fang, M., Jiang, S., Zhu, J., Fu, X., Hu, Y., Pan, S., Jiang, H., Lin, J. J., Yuan, J., Li, P., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113393 · Cited by 21
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma
Bernat‐Peguera, A., Navarro-Ventura, J., Lorenzo-Sanz, L., da Silva-Diz, V., Bosio, M., Palomero, L., Penin, R. M., Sidelnikova, D. P., Bermejo, J. O., Taberna, M., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0232 · Cited by 21
Lenvatinib for effectively treating antiangiogenic drug-resistant nasopharyngeal carcinoma
Sun, Q., Wang, Y., Ji, H. L., Sun, X., Xie, S., Chen, L., Li, S., Zeng, W., Chen, R., Tang, Q., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05171-3 · Cited by 21
Endothelial cell diversity: the many facets of the crystal
Pérez, L., Li, P., & Ferrara, N. (2022) · FEBS Journal · doi:10.1111/febs.16660 · Cited by 22
Current Biomarkers for Carotid Artery Stenosis: A Comprehensive Review of the Literature
Khan, H., Shaikh, F., Syed, M. H., Mamdani, M., Saposnik, G., & Qadura, M. (2023) · Metabolites · doi:10.3390/metabo13080919 · Cited by 21
Antineoplastic drugs inducing cardiac and vascular toxicity – An update
Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., Guevara, M. M. M., Ferdinandy, P., & Madonna, R. (2023) · Vascular Pharmacology · doi:10.1016/j.vph.2023.107223 · Cited by 23
Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs
Gędaj, A., Gregorczyk, P., Żukowska, D., Chorążewska, A., Ciura, K., Kalka, M., Porębska, N., & Opaliński, Ł. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.04.001 · Cited by 22
Lin, J., Jia, Y., Zeng, W., Mi, Y., & Zhang, C. (2011) · Reproduction in Domestic Animals · doi:10.1111/j.1439-0531.2011.01813.x · Cited by 21
Fábián, Z., Ramadurai, S., Shaw, G., Nasheuer, H., Kölch, W., Taylor, C. T., & Barry, F. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.02.007 · Cited by 22
Mori, S., & Takada, Y. (2013) · Medical Sciences · doi:10.3390/medsci1010020 · Cited by 20
Lee, E. K., Martínez, M. C. R., Blakely, K. M., Santos, K. D., Hoang, V. C., Chow, A., & Emmenegger, U. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.08.005 · Cited by 21
Santos, E. S., Gomez, J. E., & Raez, L. E. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9644-2 · Cited by 21
Common pathways for growth and for plasticity
Knafo, S., & Esteban, J. A. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.02.008 · Cited by 24
di Martino, E., Kelly, G. P., Roulson, J., & Knowles, M. A. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0022 · Cited by 21
Novel FGF10 mutation in autosomal dominant aplasia of lacrimal and salivary glands
Seymen, F., Koruyucu, M., Toptancı, İ. R., Balsak, S., Dedeoğlu, S., Çelepkolu, T., Shin, T. J., Hyun, H., Kim, Y., & Kim, J. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1771-x · Cited by 21
REV-ERBα regulates Fgf21 expression in the liver via hepatic nuclear factor 6
Chavan, R., Preitner, N., Okabe, T., Mansencal-Strittmatter, L., Xu, C., Ripperger, J. A., Pitteloud, N., & Albrecht, U. (2016) · Biology Open · doi:10.1242/bio.021519 · Cited by 22
Chen, T., Gong, W., Tian, H., Wang, H., Chu, S., Ma, J., Yang, H., Cheng, J., Liu, M., Li, X., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.5301 · Cited by 21
Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology
Zarredar, H., Ansarin, K., Baradaran, B., Khosroshahi, S. A., & Farajnia, S. (2018) · Cancer Investigation · doi:10.1080/07357907.2017.1416393 · Cited by 21
Raggi, C., Fiaccadori, K., Pastore, M., Correnti, M., Piombanti, B., Forti, E., Navari, N., Abbadessa, G., Hall, T. G., Destro, A., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.06.007 · Cited by 21
Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
Jomrich, G., Hudec, X., Harpain, F., Winkler, D., Timelthaler, G., Mohr, T. T., Marian, B., & SCHOPPMANN, S. F. (2019) · Cells · doi:10.3390/cells8091092 · Cited by 21
Homeoprotein transduction in neurodevelopment and physiopathology
Nardo, A. A. D., Joliot, A., & Prochiantz, A. (2020) · Science Advances · doi:10.1126/sciadv.abc6374 · Cited by 20
Association of fibroblast growth factor 21 with alcohol consumption and alcohol liver cirrhosis
Wagner‐Skacel, J., Horvath, A., Grande, P., Wenninger, J., Matzer, F., Fazekas, C., Mörkl, S., Meinitzer, A., & Stadlbauer, V. (2020) · Neuropsychiatrie · doi:10.1007/s40211-020-00380-8 · Cited by 21
Metadata
- Authors
- Beenken, A., & Mohammadi, M.
- Affiliations
- New York University (US)
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-03
- Volume
- 8
- Issue
- 3
- Pages
- 235-253
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3684054
- OpenAlex
- W2027239974
- Cited by
- 1,945
- References
- 281
- Citations by year
- 2026: 71 · 2025: 112 · 2024: 114 · 2023: 132 · 2022: 127 · 2021: 125 · 2020: 141 · 2019: 123 · 2018: 114 · 2017: 121 · 2016: 119 · 2015: 126 · 2014: 129 · 2013: 97 · 2012: 111
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (T32-GM066704-05, T32GM066704)
- National Institute of Dental and Craniofacial Research (R01DE13686, R01DE013686)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- fibroblast growth factor, cancer therapy, cardiovascular disease, metabolic syndrome, FGF19, bile acid homeostasis, glucose homeostasis, phosphate homeostasis, angiogenesis, brain patterning, limb development, branching morphogenesis
- MeSH terms
- Animals, Cardiovascular Diseases, Fibroblast Growth Factors, Homeostasis, Humans, Neoplasms, Receptors, Fibroblast Growth Factor, Hypophosphatemia, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review